- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-6-1-1-mer
- Ligands
- 3 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 18 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG-NAG.2: 4 residues within 4Å:- Chain A: N.264, S.293, N.448
- Ligands: NAG-NAG-BMA-MAN-MAN.1
No protein-ligand interaction detected (PLIP)NAG-NAG.3: 3 residues within 4Å:- Chain A: Q.295, N.297, N.333
No protein-ligand interaction detected (PLIP)NAG-NAG.4: 5 residues within 4Å:- Chain A: W.98, N.236, T.238, S.276
- Ligands: NAG.23
No protein-ligand interaction detected (PLIP)NAG-NAG.5: 3 residues within 4Å:- Chain A: R.194, N.199, T.200
No protein-ligand interaction detected (PLIP)NAG-NAG.6: 5 residues within 4Å:- Chain A: V.136, N.150, Y.167, L.169, D.322
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:Y.167
NAG-NAG.7: 3 residues within 4Å:- Chain A: N.303, I.324, V.442
No protein-ligand interaction detected (PLIP)NAG-NAG.8: 6 residues within 4Å:- Chain A: N.297, T.299, H.331, N.333, S.413, T.415
No protein-ligand interaction detected (PLIP)NAG-NAG.10: 4 residues within 4Å:- Chain C: N.264, S.293, N.448
- Ligands: NAG-NAG-BMA-MAN-MAN.9
No protein-ligand interaction detected (PLIP)NAG-NAG.11: 2 residues within 4Å:- Chain C: N.297, N.333
No protein-ligand interaction detected (PLIP)NAG-NAG.12: 6 residues within 4Å:- Chain C: V.176, R.194, I.196, N.199, T.200
- Chain E: R.310
2 PLIP interactions:2 interactions with chain C- Hydrophobic interactions: C:V.176, C:I.196
NAG-NAG.13: 3 residues within 4Å:- Chain C: N.150, Y.167, L.169
1 PLIP interactions:1 interactions with chain C- Hydrophobic interactions: C:Y.167
NAG-NAG.14: 3 residues within 4Å:- Chain C: H.87, T.242, N.243
No protein-ligand interaction detected (PLIP)NAG-NAG.15: 6 residues within 4Å:- Chain C: N.297, T.299, H.331, N.333, T.415, R.444
No protein-ligand interaction detected (PLIP)NAG-NAG.17: 4 residues within 4Å:- Chain E: N.264, S.293, N.448
- Ligands: NAG-NAG-BMA-MAN-MAN.16
No protein-ligand interaction detected (PLIP)NAG-NAG.18: 6 residues within 4Å:- Chain A: R.310
- Chain E: V.176, R.194, I.196, N.199, T.200
1 PLIP interactions:1 interactions with chain E- Hydrophobic interactions: E:I.196
NAG-NAG.19: 2 residues within 4Å:- Chain E: N.303, V.442
No protein-ligand interaction detected (PLIP)NAG-NAG.20: 4 residues within 4Å:- Chain E: E.89, N.90
- Chain F: G.527, S.528
No protein-ligand interaction detected (PLIP)NAG-NAG.21: 6 residues within 4Å:- Chain E: N.297, T.299, H.331, N.333, T.415, R.444
No protein-ligand interaction detected (PLIP)- 44 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.22: 4 residues within 4Å:- Chain A: Q.132, S.152, F.153, N.154
Ligand excluded by PLIPNAG.23: 4 residues within 4Å:- Chain A: N.278, T.280, N.281
- Ligands: NAG-NAG.4
Ligand excluded by PLIPNAG.24: 5 residues within 4Å:- Chain A: T.373, T.374, N.387, S.389
- Ligands: NAG.25
Ligand excluded by PLIPNAG.25: 6 residues within 4Å:- Chain A: N.364, S.365, S.366, G.367, T.373
- Ligands: NAG.24
Ligand excluded by PLIPNAG.26: 4 residues within 4Å:- Chain A: C.133, T.134, N.135, Y.193
Ligand excluded by PLIPNAG.27: 5 residues within 4Å:- Chain A: E.89, N.90
- Chain B: G.524, G.527, S.528
Ligand excluded by PLIPNAG.28: 3 residues within 4Å:- Chain A: H.87, K.233, N.243
Ligand excluded by PLIPNAG.29: 4 residues within 4Å:- Chain A: E.270, E.271, N.291, E.292
Ligand excluded by PLIPNAG.30: 3 residues within 4Å:- Chain A: K.336, N.340, W.396
Ligand excluded by PLIPNAG.31: 1 residues within 4Å:- Chain A: N.356
Ligand excluded by PLIPNAG.32: 2 residues within 4Å:- Chain A: S.389, N.393
Ligand excluded by PLIPNAG.33: 6 residues within 4Å:- Chain B: K.633, E.634, I.635, S.636, N.637, Y.638
Ligand excluded by PLIPNAG.34: 2 residues within 4Å:- Chain B: N.611, S.613
Ligand excluded by PLIPNAG.35: 4 residues within 4Å:- Chain C: S.152, F.153, N.154, K.165
Ligand excluded by PLIPNAG.36: 4 residues within 4Å:- Chain C: N.278, I.279, T.280, N.281
Ligand excluded by PLIPNAG.37: 5 residues within 4Å:- Chain C: T.373, T.374, N.387, S.389
- Ligands: NAG.38
Ligand excluded by PLIPNAG.38: 5 residues within 4Å:- Chain C: N.364, S.365, S.366, T.373
- Ligands: NAG.37
Ligand excluded by PLIPNAG.39: 5 residues within 4Å:- Chain C: N.236, T.238, S.276, E.277, I.279
Ligand excluded by PLIPNAG.40: 3 residues within 4Å:- Chain C: N.135, G.146, R.172
Ligand excluded by PLIPNAG.41: 3 residues within 4Å:- Chain C: N.303, I.324, V.442
Ligand excluded by PLIPNAG.42: 2 residues within 4Å:- Chain C: E.89, N.90
Ligand excluded by PLIPNAG.43: 4 residues within 4Å:- Chain C: E.269, E.270, N.291, K.345
Ligand excluded by PLIPNAG.44: 4 residues within 4Å:- Chain C: N.340, S.394, T.395, W.396
Ligand excluded by PLIPNAG.45: 1 residues within 4Å:- Chain C: N.356
Ligand excluded by PLIPNAG.46: 3 residues within 4Å:- Chain C: S.389, G.390, N.393
Ligand excluded by PLIPNAG.47: 2 residues within 4Å:- Chain C: N.138, N.139
Ligand excluded by PLIPNAG.48: 3 residues within 4Å:- Chain D: I.635, S.636, N.637
Ligand excluded by PLIPNAG.49: 2 residues within 4Å:- Chain D: N.618, E.621
Ligand excluded by PLIPNAG.50: 2 residues within 4Å:- Chain D: N.611, S.613
Ligand excluded by PLIPNAG.51: 4 residues within 4Å:- Chain E: Q.132, S.152, F.153, N.154
Ligand excluded by PLIPNAG.52: 3 residues within 4Å:- Chain E: N.278, T.280, N.281
Ligand excluded by PLIPNAG.53: 6 residues within 4Å:- Chain E: Q.295, N.297, N.333, S.335, S.413, R.444
Ligand excluded by PLIPNAG.54: 6 residues within 4Å:- Chain E: T.373, T.374, N.387, S.389, R.419
- Ligands: NAG.55
Ligand excluded by PLIPNAG.55: 6 residues within 4Å:- Chain E: N.364, S.365, S.366, G.367, T.373
- Ligands: NAG.54
Ligand excluded by PLIPNAG.56: 5 residues within 4Å:- Chain E: N.236, T.238, S.276, E.277, I.279
Ligand excluded by PLIPNAG.57: 3 residues within 4Å:- Chain E: N.135, K.191
- Chain H: X.88
Ligand excluded by PLIPNAG.58: 2 residues within 4Å:- Chain E: K.231, N.243
Ligand excluded by PLIPNAG.59: 4 residues within 4Å:- Chain E: E.269, E.270, E.271, N.291
Ligand excluded by PLIPNAG.60: 3 residues within 4Å:- Chain E: K.336, N.340, W.396
Ligand excluded by PLIPNAG.61: 1 residues within 4Å:- Chain E: N.356
Ligand excluded by PLIPNAG.62: 2 residues within 4Å:- Chain E: S.389, N.393
Ligand excluded by PLIPNAG.63: 2 residues within 4Å:- Chain F: S.636, N.637
Ligand excluded by PLIPNAG.64: 3 residues within 4Å:- Chain F: N.618, S.620, E.621
Ligand excluded by PLIPNAG.65: 2 residues within 4Å:- Chain F: N.611, S.613
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Antanasijevic, A. et al., Polyclonal antibody responses to HIV Env immunogens resolved using cryoEM. Nat Commun (2021)
- Release Date
- 2021-08-04
- Peptides
- Envelope glycoprotein gp160: ABCDEF
Rh.33172 pAbC-1 Heavy Chain: G
Rh.33172 pAbC-1 Light Chain: H - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
CB
DC
ED
FE
AF
BG
HH
L
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-6-1-1-mer
- Ligands
- 3 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 18 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 44 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Antanasijevic, A. et al., Polyclonal antibody responses to HIV Env immunogens resolved using cryoEM. Nat Commun (2021)
- Release Date
- 2021-08-04
- Peptides
- Envelope glycoprotein gp160: ABCDEF
Rh.33172 pAbC-1 Heavy Chain: G
Rh.33172 pAbC-1 Light Chain: H - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
CB
DC
ED
FE
AF
BG
HH
L